326 related articles for article (PubMed ID: 34936067)
1. Ocular Fluid Mechanics and Drug Delivery: A Review of Mathematical and Computational Models.
Bhandari A
Pharm Res; 2021 Dec; 38(12):2003-2033. PubMed ID: 34936067
[TBL] [Abstract][Full Text] [Related]
2. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
Shen J; Lu GW; Hughes P
Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
4. A review on recent drug delivery systems for posterior segment of eye.
Nayak K; Misra M
Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
[TBL] [Abstract][Full Text] [Related]
5. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based ocular pharmacokinetic modeling using computational methods.
Missel PJ; Sarangapani R
Drug Discov Today; 2019 Aug; 24(8):1551-1563. PubMed ID: 31319151
[TBL] [Abstract][Full Text] [Related]
7. Nanomaterials for ocular drug delivery.
Liu S; Jones L; Gu FX
Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
[TBL] [Abstract][Full Text] [Related]
8. Cell penetrating peptides in ocular drug delivery: State of the art.
Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
[TBL] [Abstract][Full Text] [Related]
9. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
10. Delivery of therapeutics for deep-seated ocular conditions - status quo.
Nguyen H; Eng S; Ngo T; Dass CR
J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
[TBL] [Abstract][Full Text] [Related]
11. Ocular drug delivery-eye on innovation.
Rupenthal ID; O'Rourke M
Drug Deliv Transl Res; 2016 Dec; 6(6):631-633. PubMed ID: 27766597
[No Abstract] [Full Text] [Related]
12. ISOPT
Kompella UB; Domb A; Urtti A; Jayagopal A; Wilson CG; Tang-Liu D
J Ocul Pharmacol Ther; 2019 Oct; 35(8):457-465. PubMed ID: 31259643
[TBL] [Abstract][Full Text] [Related]
13. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
Üstündağ Okur N; Çağlar EŞ; Siafaka PI
J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Topical Ocular Drug Delivery.
Yellepeddi VK; Palakurthi S
J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
[TBL] [Abstract][Full Text] [Related]
15. Trans-scleral delivery of macromolecules.
Pescina S; Santi P; Ferrari G; Nicoli S
Ther Deliv; 2011 Oct; 2(10):1331-49. PubMed ID: 22826887
[TBL] [Abstract][Full Text] [Related]
16. Nanoplatforms for Delivery of siRNA to the Eye.
Kataki MS; Kakoti BB; Jameson M; Solanki A; Hirani A; Pathak Y
Curr Pharm Des; 2015; 21(31):4587-93. PubMed ID: 26486145
[TBL] [Abstract][Full Text] [Related]
17. Nanotherapies for the treatment of ocular diseases.
Reimondez-Troitiño S; Csaba N; Alonso MJ; de la Fuente M
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):279-93. PubMed ID: 25725262
[TBL] [Abstract][Full Text] [Related]
18. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
19. Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy.
Swetledge S; Jung JP; Carter R; Sabliov C
J Nanobiotechnology; 2021 Jan; 19(1):10. PubMed ID: 33413421
[TBL] [Abstract][Full Text] [Related]
20. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Molina-Martínez IT
Expert Opin Drug Deliv; 2021 Jul; 18(7):819-847. PubMed ID: 33412914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
